<DOC>
	<DOCNO>NCT01171781</DOCNO>
	<brief_summary>The study try show weekly cisplatin base CCRT inferior 3-weekly cisplabe base CCRT term 3-yr progression free survival rate advance nasopharyngeal carcinoma</brief_summary>
	<brief_title>A Randomized Phase II Study Concurrent Chemoradiation With Every 3 Week Cisplatin v With Weekly Cisplatin Locally Advanced Nasopharyngeal Carcinoma</brief_title>
	<detailed_description />
	<mesh_term>Carcinoma</mesh_term>
	<mesh_term>Nasopharyngeal Neoplasms</mesh_term>
	<mesh_term>Cisplatin</mesh_term>
	<criteria>histologically confirm nasopharyngeal carcinoma age 18 year stage II ~ IVb history chemotherapy , radiotherapy , immunotherapy NPC measurable lesion base RECIST 1.1 ECOG PS 0 ~2 good organ function ( liver , renal , hematologic ) active infectious disease require antibiotic uncontrolled heart disease pregnancy feed state history malignancy within 5 year enrollment , except well treat nonmelanomatous skin cancer , situ cervical cancer , thyroid cancer</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>July 2010</verification_date>
</DOC>